⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
HIMS News
Hims & Hers Health, Inc.
Hims & Hers Health Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Hims & Hers Health, Inc. - HIMS
businesswire.com
HIMS
Novo Nordisk expands US patient access to FDA-approved semaglutide medicines through Hims & Hers in response to a shift in their US GLP-1 business model
globenewswire.com
HIMS
YieldMax® ETFs Announces Weekly Distributions for Group 2 ETFs
globenewswire.com
TSLA
AAPL
NVDA
AMZN
META
GOOGL
NFLX
COIN
MSFT
DIS
XOM
JPM
AMD
PYPL
MRNA
AI
MSTR
SNOW
ABNB
BABA
TSM
SMCI
PLTR
MARA
CVNA
HOOD
BRK.B
DKNG
RBLX
RDDT
GME
HIMS
CRCL
Glancy Prongay Wolke & Rotter LLP Announces Investigation of Hims & Hers Health, Inc. (HIMS) on Behalf of Investors
businesswire.com
HIMS
Law Offices of Howard G. Smith Announces Investigation of Hims & Hers Health, Inc. (HIMS) on Behalf of Investors
businesswire.com
HIMS
The Law Offices of Frank R. Cruz Announces Investigation of Hims & Hers Health, Inc. (HIMS) on Behalf of Investors
businesswire.com
HIMS
YieldMax® ETFs Announces Weekly Distributions for Group 2 ETFs
globenewswire.com
TSLA
AAPL
NVDA
AMZN
META
GOOGL
NFLX
COIN
MSFT
DIS
XOM
JPM
AMD
PYPL
MRNA
AI
MSTR
SNOW
ABNB
BABA
TSM
SMCI
PLTR
MARA
CVNA
HOOD
BRK.B
DKNG
RBLX
RDDT
GME
HIMS
CRCL
Bronstein, Gewirtz & Grossman, LLC Is Investigating Hims & Hers Health, Inc. (HIMS) And Encourages Shareholders to Connect
accessnewswire.com
HIMS
Form 8-K
sec.gov
HIMS
Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results
businesswire.com
HIMS